We currently sponsor 25 research studies that answer key questions on optimizing the delivery of artemisinin-based combination therapy (ACT) - the first-line treatment recommended by the WHO for malaria - in Africa and Asia.
We are taking a multi-disciplinary approach to our work, looking at the effectiveness of ACTs over time, cost-effectiveness of delivery strategies, acceptability, safety, and how to improve ACT use by prescribers and patients. We are testing a range of strategies based on Rapid Diagnostic Tests and targeted behaviour change communication methods.
The Project Profiles give you more detailed information about each study, and our Publications section provides you with a list of all peer-reviewed journal articles published by the ACT Consortium. Please sign up to receive updates from us on how our work is progressing. If you have any questions about any of our studies, please let us know.
We also produce Useful resources to improve the quality of research being done in the field. These guidelines were created to benefit our consortium members as well as other colleagues from around the world involved in researching ACTs and their use in malaria endemic countries.